FDA Denies Priority Review For GlaxoSmithKline’s HPV Vaccine Cervarix

Decision could give Merck’s Gardasil an extra four months without HPV vaccine competition.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet